Time travel has long lived in the realm of science fiction, but a prominent futurist now argues that humans could effectively ...

KAIST researchers have developed a way to reprogram immune cells already inside tumors into cancer-killing machines. A drug ...

A researcher is planning on investigating potential treatments aimed at the root causes of type 1 diabetes. At the (MUSC), ...

As of Friday, January 09, Enlivex Therapeutics Ltd.’s ENLV share price has surged by 5.02%, which has investors questioning ...

Early experiments suggest that reprogramming plant immune receptors could one day slash the world’s dependence on nitrogen ...

GC Therapeutics, Inc. (GCTx), a biotechnology company created to scale and unlock the next generation of cell therapy-based medicines through its TFome™ cellular programming platform, today announced ...

Scientists are racing to redesign how powerful painkillers work, aiming to keep the relief that opioids provide while ...

Victoria Gray spent 34 years battling the debilitating pain of sickle cell disease. Then she volunteered to be the world's first "prototype" for a CRISPR therapy, based on technology invented at UC ...

A naturopathic case exploring how structured somatic medicine can support nervous system regulation, emotional processing, ...

For the first time, researchers at the University of British Columbia have demonstrated how to reliably produce an important ...

In the battle against type 1 diabetes (T1D), one researcher at the Medical University of South Carolina (MUSC) is leading a ...

The rich are increasingly looking for properties that can accommodate extended families. Mllennials and Gen Xers are driving ...